Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Fusion Pharmaceuticals Files For Mixed Securities Shelf Offering Of Up To $400M

-SEC Filing

byMichael Horton

July 2, 2021

1 minute read

-SEC Filing

Mullen Shares Pop On Cargo Van Deal With Amazon Delivery Services Partner DelPack

By Shivani Kumaresan

Today, 8:42 AM

Mullen Automotive Inc (NASDAQ:MULN) has signed a binding agreement with DelPack Logistics LLC (DPL) for cargo vans. DelPack is an Amazon.Com, Inc.(NASDAQ:AMZN)…

AMZN

Needham Maintains Buy on GLOBALFOUNDRIES, Raises Price Target to $87

By Benzinga Newsdesk

Today, 8:42 AM

Needham analyst Rajvindra Gill maintains GLOBALFOUNDRIES (NASDAQ:GFS) with a Buy and raises the price target from $85 to $87.

GFS

Acceleron Pharma Q3 EPS $(1.16) Down From $(0.66) YoY, Sales $34.20M Up From $22.56M YoY

By Benzinga Newsdesk

Today, 8:42 AM

Acceleron Pharma (NASDAQ:XLRN) reported quarterly losses of $(1.16) per share. This is a 75.76 percent decrease over losses of $(0.66) per share from the same period last year. The company reported $34.20 million in

XLRN

Legal
News

Assistant Attorney General Jonathan Kanter for the Antitrust Division Said ‘We Respectfully Disagree With the Court’s Decision and Are Reviewing the Opinion Closely to Evaluate Next Steps’

By Charles Gross

Today, 8:42 AM

Assistant Attorney General Jonathan Kanter for the Antitrust Division issued the following statement regarding the District Court's decision in U.S. v. United Healthcare Group and Change Healthcare.

CHNG

Fusion Pharmaceuticals Files For Mixed Securities Shelf Offering Of Up To $400M

Related Posts

Mullen Shares Pop On Cargo Van Deal With Amazon Delivery Services Partner DelPack

Needham Maintains Buy on GLOBALFOUNDRIES, Raises Price Target to $87

Acceleron Pharma Q3 EPS $(1.16) Down From $(0.66) YoY, Sales $34.20M Up From $22.56M YoY

Assistant Attorney General Jonathan Kanter for the Antitrust Division Said ‘We Respectfully Disagree With the Court’s Decision and Are Reviewing the Opinion Closely to Evaluate Next Steps’